Why the study?
Does 18F-FDG PET provide high diagnostic accuracy for cardiac sarcoidosis compared with the MHLW guidelines?
Does 18F-FDG PET provide high diagnostic accuracy for cardiac sarcoidosis compared with the MHLW guidelines?
18F-FDG PET demonstrates high diagnostic accuracy for cardiac sarcoidosis, supporting its clinical use.
Supports 18F-FDG PET integration into cardiac sarcoidosis diagnostics; reinforces Level 1 meta-analytic confirmation versus MHLW guidelines.
The high diagnostic accuracy determined for (18)F-FDG PET in this metaanalysis suggests potential value for diagnosis of cardiac sarcoidosis compared with the MHLW guidelines. These results may affect patient care by providing supportive evidence for more effective use of (18)F-FDG PET in the diagnosis of cardiac sarcoidosis. Large-scale multicenter studies are required to further evaluate this role.
No takes yet. Share an insight, caveat, or question.
Youssef et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: